ADB International Group's Licensor Set to Receive International
Patent Approval for Commercial Wastewater Purification
Technology
SAN ANTONIO, July 30, 2013 /PRNewswire/ -- ADB
International Group, Inc. (OTCQB: ADBI), a distributor of advanced
water treatment systems manufactured by Treatec21 Industries Ltd,
today announced that Treatec21's proprietary industrial wastewater
purification technology has successfully passed the preliminary
stages as a prerequisite for approval of its comprehensive
international patent application.
ADBI International was recently appointed as the distributor of
Treatec21 state-of-the-art water and wastewater treatment
technology systems in Australia
and New Zealand on an exclusive
basis and in North America on a
non-exclusive basis.
Treatec21 recently received an International Preliminary Report
on Patentability which report noted that the 45 claims included in
Treatec21's patent request on its sophisticated chemical reactor
utilized to treat various biological stages of wastewater without
surplus wastewater sludge, were all accepted as patentable.
The international patent application was submitted and filed
during the 2nd and 3rd fiscal quarters of 2012, in multiple
countries including Australia.
According to Treatec21's patent counsel and consultant, there is a
high likelihood that the patent applications will be
accepted.
Treatec21, a subsidiary of YAAD Industrial Ltd, listed on the
Tel Aviv Stock Exchange, specializes in developing, manufacturing
and operating advanced water and wastewater treatment systems using
state of the art Multi-Stage Biological Treatment (MSBT)
technology, which results in no surplus of organic sludge.
Treatec21 products are fully commercial in Israel and Europe, are involved in a major installation
in China and are expected to soon
be commercially successful in India, Africa
and across the globe.
"We are very pleased that Treatec21's state-of-the-art water and
wastewater treatment technology systems that ADB International is
licensed to distribute will be patent protected in our Australia/New
Zealand region," said Shahar
Ginsberg, recently appointed CEO of ADB International. "Such
patents will bring added value and strength to our business
development efforts in that region, as well as in North America where we are a licensed on a
non-exclusive basis, and increase our potential for signing
commercial wastewater purification projects."
For more information on ADB International, please visit
http://adbintl.com. For more information on the Treatec21 and
MSBT, please visit http://treatec21.com.
Forward-Looking Statements
This letter contains forward-looking statements within the
meaning of Section 27A of the Securities Act of 1933, as amended
and Section 21E of the Securities Exchange Act of 1934, as amended.
All forward-looking statements are inherently uncertain. In
evaluating such statements, prospective investors should review
carefully various risks and uncertainties identified in this
release, as actual results may differ materially from those
indicated. ADBI International Group public filings may be
viewed at www.sec.gov.
Contact:
Shahar Ginsberg CEO
Shahar@adbintl.com
Tel: 1-866-483-9414 705
SOURCE ADB International Group, Inc.